MXPA03001964A - Metodo para el tratamiento de alergias usando pirazoles substituidos. - Google Patents

Metodo para el tratamiento de alergias usando pirazoles substituidos.

Info

Publication number
MXPA03001964A
MXPA03001964A MXPA03001964A MXPA03001964A MXPA03001964A MX PA03001964 A MXPA03001964 A MX PA03001964A MX PA03001964 A MXPA03001964 A MX PA03001964A MX PA03001964 A MXPA03001964 A MX PA03001964A MX PA03001964 A MXPA03001964 A MX PA03001964A
Authority
MX
Mexico
Prior art keywords
substituted pyrazoles
treating allergies
treating
allergies
pyrazoles
Prior art date
Application number
MXPA03001964A
Other languages
English (en)
Inventor
James P Edwards
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/928,122 external-priority patent/US7309703B2/en
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA03001964A publication Critical patent/MXPA03001964A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describe un metodo para el tratamiento de una condicion alergica que incluye una condicion alergica atopica, usando pirazoles substituidos de la formula l. (ver formula).
MXPA03001964A 2000-09-06 2001-09-05 Metodo para el tratamiento de alergias usando pirazoles substituidos. MXPA03001964A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23040700P 2000-09-06 2000-09-06
US09/928,122 US7309703B2 (en) 2000-08-14 2001-08-10 Substituted pyrazoles
PCT/US2001/027479 WO2002020012A2 (en) 2000-09-06 2001-09-05 Method for treating allergies using substituted pyrazoles

Publications (1)

Publication Number Publication Date
MXPA03001964A true MXPA03001964A (es) 2004-03-26

Family

ID=26924204

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001964A MXPA03001964A (es) 2000-09-06 2001-09-05 Metodo para el tratamiento de alergias usando pirazoles substituidos.

Country Status (15)

Country Link
EP (1) EP1315491B1 (es)
JP (1) JP2004508329A (es)
CN (1) CN100384420C (es)
AT (1) ATE335472T1 (es)
AU (2) AU2001288730B2 (es)
CA (1) CA2421505A1 (es)
CY (1) CY1106196T1 (es)
DE (1) DE60122171T2 (es)
DK (1) DK1315491T3 (es)
ES (1) ES2269454T3 (es)
HK (1) HK1053606A1 (es)
MX (1) MXPA03001964A (es)
NZ (1) NZ524680A (es)
PT (1) PT1315491E (es)
WO (1) WO2002020012A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002014314A2 (en) * 2000-08-14 2002-02-21 Ortho Mcneil Pharmaceutical, Inc. Substituted pyrazoles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944312B2 (ja) * 1974-11-22 1984-10-29 中外製薬株式会社 インダゾ−ル誘導体の製法
JPS5936627B2 (ja) * 1975-07-25 1984-09-05 中外製薬株式会社 インダゾ−ル誘導体の製法
DK27383A (da) * 1982-02-17 1983-08-18 Lepetit Spa Fremgangsmaade til fremstilling af pyrazol(4,3-c)pyridiner
JPH0615542B2 (ja) * 1986-07-22 1994-03-02 吉富製薬株式会社 ピラゾロピリジン化合物
WO1998056785A1 (fr) * 1997-06-12 1998-12-17 Sumitomo Pharmaceuticals Co., Ltd. Derives de pyrazole

Also Published As

Publication number Publication date
CN100384420C (zh) 2008-04-30
EP1315491B1 (en) 2006-08-09
CY1106196T1 (el) 2011-06-08
DK1315491T3 (da) 2006-10-30
EP1315491A2 (en) 2003-06-04
HK1053606A1 (en) 2003-10-31
NZ524680A (en) 2004-09-24
PT1315491E (pt) 2006-10-31
AU2001288730B2 (en) 2006-01-19
CA2421505A1 (en) 2002-03-14
WO2002020012A2 (en) 2002-03-14
ATE335472T1 (de) 2006-09-15
CN1482911A (zh) 2004-03-17
JP2004508329A (ja) 2004-03-18
WO2002020012A3 (en) 2002-06-13
ES2269454T3 (es) 2007-04-01
DE60122171T2 (de) 2007-07-05
AU8873001A (en) 2002-03-22
DE60122171D1 (de) 2006-09-21

Similar Documents

Publication Publication Date Title
MXPA03001963A (es) Un metodo para tratar alergias usando pirazoles sustituidos.
ZA200302637B (en) A method for treating allergies using substituted pyrazoles.
TW200707466A (en) Conductive patterning
GB2377301A (en) Methods and apparatus for on-line ordering
AU2002224893A1 (en) Method for producing a part and device for carrying out this method
IL156584A0 (en) Substituted triazole diamine derivatives as kinase inhibitors
DE60040173D1 (de) Präsenz- und sitzungsbehandlungsinformationen
MXPA03001962A (es) Metodo para tratar alergias utilizando pirazoles sustituidos.
HK1091617A1 (en) A system and associated method to determine authentication priority between devices
AU9393101A (en) Scorch-delaying composition
NO20024657D0 (no) Bössing innbefattende et terminalöre, og fremgangsmåte for produksjon av bössingen
MXPA03001964A (es) Metodo para el tratamiento de alergias usando pirazoles substituidos.
SG140447A1 (en) Method of forming a micro-rotating device, and a micro-rotating device produced by the method
AU2003266549A1 (en) Receiver-side-led communication method, communication apparatus and communication program
WO2005030906A3 (de) Antioxidationsmittel für organisches material und verfahren zur behandlung desselben
AU2000268765A1 (en) Method for manufacturing tapped coil, tapped coil, and apparatus for manufacturing tapped coil
IL161079A0 (en) A strain of streptomyces flavidovirens and process for the manufacture of pravastatin utilizing the same
AU2002258970A1 (en) Method for treating iron based parts
ITRM20010197A0 (it) Dispositivo, apparato e metodo per elettrostimolazione.
ITRM20010195A0 (it) Dispositivo, apparato e metodo per elettrostimolazione.
AU2001239539A1 (en) Information providing apparatus, information providing method, and program

Legal Events

Date Code Title Description
FG Grant or registration